Results revealed a significant up-regulation of MCL1 and CCND1, and a significant down-regulation of IGF1R and PTEN in KIRC patients with varying cancer stages, races, genders, and age groups compared to normal controls (Fig. 3). The gene discussed is MCL1; the disease is cancer.